Ab Science
Clinical trials sponsored by Ab Science, explained in plain language.
-
New drug trial aims to slow devastating ALS progression
Disease control Not yet recruitingThis study is testing whether adding an oral drug called masitinib to the standard ALS medication (riluzole) can better slow the disease and improve daily function. It will involve 412 adults with ALS who are already taking riluzole. Participants will be randomly assigned to rece…
Phase: PHASE3 • Sponsor: AB Science • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope pill aims to slow Alzheimer's memory loss
Disease control Not yet recruitingThis large Phase 3 trial will test if adding an experimental oral drug called masitinib to standard Alzheimer's medications can safely slow down the progression of the disease. The study will involve 600 people with mild Alzheimer's who are already taking stable doses of their cu…
Phase: PHASE3 • Sponsor: AB Science • Aim: Disease control
Last updated Mar 04, 2026 15:30 UTC